Arch Biopartners Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-26 Financing
Report of exempt distribution (45-106F1) (amended).pdf
News 2026-05-22
Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial
News release - English.pdf
News 2026-04-30
Arch Biopartners Announces Royal Columbian Hospital Begins Patient Recruitment in Phase II Trial of LSALT Peptide Targeting CS-AKI
News release - English.pdf
Transactions 2026-04-12 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-04-12 Financing
Arch Biopartners Inc. Closes Private Placement Offering of 1,000,000 Common Shares for Gross Proceeds of $600,000
Material change report - English.pdf
Transactions 2026-04-02 Financing
Arch Biopartners Closes Non-Brokered Private Placement
News release - English.pdf
Transactions 2026-03-30 Financing
Arch Biopartners Arranges Non-Brokered Private Placement
News release - English.pdf
News 2026-03-24
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
News release - English.pdf
News 2026-03-20
Arch Biopartners Announces St. Michael's Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide
News release - English.pdf
Results 2026-03-03 Financials
Interim MD&A - English.pdf
Results 2026-03-03 Financials
Interim financial statements/report – English.pdf
News 2026-02-09
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
News release - English.pdf
Results 2026-01-29 Financials
Annual MD&A - English.pdf
Results 2026-01-29 Financials
Audited annual financial statements – English.pdf
News 2025-12-16
Arch Biopartners Announces Ethics Approval for St. Michael's Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
News release - English.pdf
News 2025-12-02
Report of exempt distribution (45-106F1).pdf
Transactions 2025-12-01 Financing
Arch Biopartners Inc. Closes Private Placement Offering of 576,923 Common Shares for Gross Proceeds of $600,000
Material change report - English.pdf
Transactions 2025-11-19 Financing
Arch Biopartners Closes Non-Brokered Private Placement
News release - English.pdf
News 2025-11-10
News release - English.pdf
News 2025-11-05
News release - English.pdf
News 2025-09-17
News release - English.pdf
Results 2025-08-30 Financials
Interim financial statements/report – English.pdf
Results 2025-08-30 Financials
Interim MD&A - English.pdf
News 2025-08-06
News release - English.pdf
News 2025-07-22
News release - English.pdf
Results 2025-05-31 Financials
Interim MD&A - English.pdf
Results 2025-05-31 Financials
Interim financial statements/report – English.pdf